{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:56:27Z","timestamp":1790398587515,"version":"4.1.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2006,8,1]]},"DOI":"10.1038\/ncponc0581","type":"journal-article","created":{"date-parts":[[2006,8,8]],"date-time":"2006-08-08T09:25:23Z","timestamp":1155029123000},"page":"438-447","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["The management of tumor lysis syndrome"],"prefix":"10.1038","volume":"3","author":[{"given":"Elvira","family":"Rampello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Fricia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Malaguarnera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncponc0581_CR1","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1055::AID-CNCR7>3.0.CO;2-3","volume":"85","author":"MP Castro","year":"1999","unstructured":"Castro MP  et al. (1999) Acute tumor lysis syndrome associated with concurrent biochemotherapy of metastatic melanoma: a case report and review of the literature. Cancer 85: 1055","journal-title":"Cancer"},{"key":"BFncponc0581_CR2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/BF00860751","volume":"9","author":"DP Jones","year":"1995","unstructured":"Jones DP  et al. (1995) Tumor lysis syndrome: pathogenesis and management. Pediatr Nephrol 9: 206\u2013212","journal-title":"Pediatr Nephrol"},{"key":"BFncponc0581_CR3","first-page":"245","volume":"1","author":"CS Co","year":"1983","unstructured":"Co CS  et al. (1983) Urinary uric acid excretion in patients with carcinoma of the cervix undergoing intracavitary radium therapy. Radiat Med 1: 245\u2013247","journal-title":"Radiat Med"},{"key":"BFncponc0581_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ajh.2830470212","volume":"47","author":"AM Jasek","year":"1994","unstructured":"Jasek AM and Day HJ (1994) Acute spontaneous tumor lysis syndrome. Am J Hematol 47: 129\u2013131","journal-title":"Am J Hematol"},{"key":"BFncponc0581_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1081\/JDI-120004100","volume":"24","author":"S Alkhuja","year":"2002","unstructured":"Alkhuja S and Ulrich H (2002) Acute renal failure from spontaneous acute tumor lysis syndrome: a case report and review. Ren Fail 24: 227\u2013232","journal-title":"Ren Fail"},{"key":"BFncponc0581_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/00000421-200010000-00012","volume":"23","author":"J Feld","year":"2000","unstructured":"Feld J  et al. (2000) Acute spontaneous tumor lysis syndrome in adenocarcinoma of the lung: case report. Am J Clin Oncol 23: 491\u2013493","journal-title":"Am J Clin Oncol"},{"key":"BFncponc0581_CR7","first-page":"59","volume":"54","author":"M Agha-Razii","year":"2000","unstructured":"Agha-Razii M  et al. (2000) Continuous veno-venous hemodiafiltration for the treatment of spontaneous tumor lysis syndrome complicated by acute renal failure and severe hyperuricemia. Clin Nephrol 54: 59\u201363","journal-title":"Clin Nephrol"},{"key":"BFncponc0581_CR8","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/BF01962199","volume":"50","author":"F Salkowsky","year":"1870","unstructured":"Salkowsky F (1870) Beitrage Zur Kenntins der Leukamie. Virchows Arch Pathol Anat 50: 174\u2013177","journal-title":"Virchows Arch Pathol Anat"},{"key":"BFncponc0581_CR9","first-page":"1700","volume":"25","author":"J Bedrna","year":"1929","unstructured":"Bedrna J  et al. (1929) harnleiterverschluss nach Bestrahlung chronischer leuk\u00e4mien mit r\u00f6ntgenstrahlen. Med Klin 25: 1700\u20131701","journal-title":"Med Klin"},{"key":"BFncponc0581_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1001\/archinte.1977.03630130065016","volume":"137","author":"DR Crittenden","year":"1977","unstructured":"Crittenden DR and Ackerman GL (1977) Hyperuricemic acute renal failure in disseminated carcinoma. Arch Intern Med 137: 97\u201399","journal-title":"Arch Intern Med"},{"key":"BFncponc0581_CR11","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/0002-9343(80)90286-7","volume":"68","author":"LF Cohen","year":"1980","unstructured":"Cohen LF  et al. (1980) Acute tumor lysis syndrome: a review of 37 patients with Burkitt's lymphoma. Am J Med 68: 486\u2013491","journal-title":"Am J Med"},{"key":"BFncponc0581_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0002-9343(93)90174-N","volume":"94","author":"KR Hande","year":"1993","unstructured":"Hande KR and Garrow GC (1993) Acute tumor lysis syndrome in patients with high grade non-Hodgkin lymphoma. Am J Med 94: 133\u2013139","journal-title":"Am J Med"},{"key":"BFncponc0581_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/00005792-198105000-00005","volume":"60","author":"GC Tsokos","year":"1981","unstructured":"Tsokos GC  et al. (1981) Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas. Medicine (Baltimore) 60: 218\u2013229","journal-title":"Medicine (Baltimore)"},{"key":"BFncponc0581_CR14","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/pgmj.70.827.651","volume":"70","author":"C Montalban","year":"1994","unstructured":"Montalban C  et al. (1994) Tumor lysis syndrome after treatment of chronic lymphocitic leukaemia with fludarabine. Postgrad Med J 70: 651\u2013652","journal-title":"Postgrad Med J"},{"key":"BFncponc0581_CR15","first-page":"1090","volume":"330","author":"MC Trendle","year":"1994","unstructured":"Trendle MC and Tefferi A (1994) Tumor lysis syndrome after treatment of chronic lymphocytic leukemia with cladribine. N Engl J Med 330: 1090","journal-title":"N Engl J Med"},{"key":"BFncponc0581_CR16","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJM199311183292106","volume":"329","author":"EJ Dann","year":"1993","unstructured":"Dann EJ  et al. (1993) Brief report: tumor lysis syndrome following treatment with 2-chlorodeoxyadenosine for refractory chronic lymphocitic leukaemia. N Engl J Med 329: 1547\u20131548","journal-title":"N Engl J Med"},{"key":"BFncponc0581_CR17","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1445-5994.1994.tb01473.x","volume":"24","author":"SP Mulligan","year":"1994","unstructured":"Mulligan SP and Dean MG (1994) Fludarabine causing tumor lysis syndrome in chronic lymphocitic leukaemia. Aust NZJ Med 24: 406\u2013407","journal-title":"Aust NZJ Med"},{"key":"BFncponc0581_CR18","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/00000421-199412000-00010","volume":"17","author":"P Drakos","year":"1994","unstructured":"Drakos P  et al. (1994) Tumor lysis syndrome in nonhematologic malignancies: report of a case and review of the literature. Am J Clin Oncol 17: 502\u2013505","journal-title":"Am J Clin Oncol"},{"key":"BFncponc0581_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1056\/NEJM198607243150417","volume":"315","author":"P Cech","year":"1986","unstructured":"Cech P  et al. (1986) Tumor lysis syndrome after tamoxifen flare. N Engl J Med 315: 263\u2013264","journal-title":"N Engl J Med"},{"key":"BFncponc0581_CR20","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1177\/106002809703101221","volume":"31","author":"Y Ustundag","year":"1997","unstructured":"Ustundag Y  et al. (1997) Acute tumor lysis syndrome associated with paclitaxel. Ann Pharmacother 31: 1548\u20131549","journal-title":"Ann Pharmacother"},{"key":"BFncponc0581_CR21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0002-9343(97)00153-8","volume":"103","author":"GP Kalemkerian","year":"1997","unstructured":"Kalemkerian GP  et al. (1997) Tumor lysis syndrome in small cell carcinoma and other solid tumors. Am J Med 103: 363\u2013367","journal-title":"Am J Med"},{"key":"BFncponc0581_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/jama.1983.03330280059032","volume":"249","author":"NJ Vogelzang","year":"1983","unstructured":"Vogelzang NJ  et al. (1983) Tumor lysis syndrome after induction chemotherapy of small-cell bronchogenic carcinoma. JAMA 249: 513\u2013514","journal-title":"JAMA"},{"key":"BFncponc0581_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/00000421-199002000-00003","volume":"13","author":"AM Hussein","year":"1990","unstructured":"Hussein AM and Feun LG (1990) Tumor lysis syndrome after induction chemotherapy in small-cell lung carcinoma. Am J Clin Oncol 13: 10\u201313","journal-title":"Am J Clin Oncol"},{"key":"BFncponc0581_CR24","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/00000421-199808000-00024","volume":"21","author":"DA Persons","year":"1998","unstructured":"Persons DA  et al. (1998) Tumor lysis syndrome and acute renal failure after treatment of non-small cell lung carcinoma with combination irinotecan and cisplatin. Am J Clin Oncol 21: 426\u2013429","journal-title":"Am J Clin Oncol"},{"key":"BFncponc0581_CR25","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/1097-0142(19890801)64:3<738::AID-CNCR2820640328>3.0.CO;2-Z","volume":"64","author":"JC Barton","year":"1989","unstructured":"Barton JC (1989) Tumor lysis syndrome in nonhematopoietic neoplasms. Cancer 64: 738\u2013740","journal-title":"Cancer"},{"key":"BFncponc0581_CR26","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/00000421-199702000-00020","volume":"20","author":"K Yokoi","year":"1997","unstructured":"Yokoi K  et al. (1997) Tumor lysis syndrome in invasive thymoma with peripheral blood T-cell lymphocytosis. Am J Clin Oncol 20: 86\u201389","journal-title":"Am J Clin Oncol"},{"key":"BFncponc0581_CR27","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/1097-0142(19840415)53:8<1783::AID-CNCR2820530829>3.0.CO;2-F","volume":"53","author":"GC Tomlinson","year":"1984","unstructured":"Tomlinson GC and Solberg LA Jr (1984) Acute tumor lysis syndrome with metastatic medulloblastoma: a case report. Cancer 53: 1783\u20131785","journal-title":"Cancer"},{"key":"BFncponc0581_CR28","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/mpo.2950210712","volume":"21","author":"SF Bilgrami","year":"1993","unstructured":"Bilgrami SF and Fallon BG (1993) Tumor lysis syndrome after combination chemotherapy for ovarian cancer. Med Pediatr Oncol 21: 521\u2013524","journal-title":"Med Pediatr Oncol"},{"key":"BFncponc0581_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3109\/08880019309016549","volume":"10","author":"J Khan","year":"1993","unstructured":"Khan J and Broadbent VA (1993) Tumor lysis syndrome complicating treatment of widespread metastatic abdominal rhabdomyosarcoma. Pediatr Hematol Oncol 10: 151\u2013155","journal-title":"Pediatr Hematol Oncol"},{"key":"BFncponc0581_CR30","first-page":"415","volume":"19","author":"A Khalil","year":"1998","unstructured":"Khalil A  et al. (1998) Fatal acute tumor lysis syndrome following treatment of vulvar carcinoma: case report. Eur J Gynaecol Oncol 19: 415\u2013416","journal-title":"Eur J Gynaecol Oncol"},{"key":"BFncponc0581_CR31","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1002\/1097-0142(19910415)67:8<2207::AID-CNCR2820670834>3.0.CO;2-R","volume":"67","author":"LY Dirix","year":"1991","unstructured":"Dirix LY  et al. (1991) Tumor lysis syndrome in a patient with metastatic Merkel cell carcinoma. Cancer 67: 2207\u20132210","journal-title":"Cancer"},{"key":"BFncponc0581_CR32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00277-003-0608-2","volume":"82","author":"W Wossmann","year":"2003","unstructured":"Wossmann W  et al. (2003) Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma\/leukaemia before and after introduction of prophylactic use of urate oxidase. Ann Hematol 82: 160\u2013165","journal-title":"Ann Hematol"},{"key":"BFncponc0581_CR33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00280-002-0556-x","volume":"51","author":"L Baeksgaard","year":"2003","unstructured":"Baeksgaard L and S\u00f8rensen JB (2003) Acute tumor lysis syndrome in solid tumors-a case report and review of the literature. Cancer Chemother Pharmacol 51: 187\u2013192","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFncponc0581_CR34","first-page":"125","volume":"20","author":"MA Hediger","year":"2005","unstructured":"Hediger MA  et al. (2005) Molecular physiology of urate transport. Physiology (Bethesda) 20: 125\u2013133","journal-title":"Physiology (Bethesda)"},{"key":"BFncponc0581_CR35","first-page":"322","volume":"27","author":"CD Flombaum","year":"2000","unstructured":"Flombaum CD (2000) Metabolic emergencies in the cancer patient. Semin Oncol 27: 322\u2013334","journal-title":"Semin Oncol"},{"key":"BFncponc0581_CR36","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1053\/ajem.2000.7344","volume":"18","author":"A Mattu","year":"2000","unstructured":"Mattu A  et al. (2000) Electrocardiographic manifestations of hyperkalemia. Am J Emerg Med 18: 721\u2013729","journal-title":"Am J Emerg Med"},{"key":"BFncponc0581_CR37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0736-4679(02)00578-4","volume":"23","author":"JR Shiber","year":"2003","unstructured":"Shiber JR and Mattu A (2003) Serum phosphate abnormalities in the emergency department. J Emerg Med 23: 395\u2013400","journal-title":"J Emerg Med"},{"key":"BFncponc0581_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1023\/A:1022994104070","volume":"4","author":"Body Jean-Jacques","year":"2003","unstructured":"Jean-Jacques Body and Roger Bouillon (2003) Emergencies of calcium homeostasis. Rev Endocr Metab Disorders 4: 167\u2013175","journal-title":"Rev Endocr Metab Disorders"},{"key":"BFncponc0581_CR39","first-page":"127","volume":"29","author":"H Duncan","year":"1960","unstructured":"Duncan H and Dixon AS (1960) Gout, familial hypericaemia, and renal disease. Q J Med 29: 127\u2013135","journal-title":"Q J Med"},{"key":"BFncponc0581_CR40","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/BF02474201","volume":"10","author":"WR Wilcox","year":"1972","unstructured":"Wilcox WR  et al. (1972) Solubility of uric acid and monosodium urate. Med Biol Eng 10: 522\u2013531","journal-title":"Med Biol Eng"},{"key":"BFncponc0581_CR41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000180438","volume":"14","author":"JR Klinenberg","year":"1975","unstructured":"Klinenberg JR  et al. (1975) Hyperuricemic nephropathy: pathologic features and factors influencing urate deposition. Nephron 14: 88\u201398","journal-title":"Nephron"},{"key":"BFncponc0581_CR42","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1172\/JCI108700","volume":"59","author":"JD Conger","year":"1977","unstructured":"Conger JD and Falk SA (1977) Intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy. J Clin Invest 59: 786\u2013793","journal-title":"J Clin Invest"},{"key":"BFncponc0581_CR43","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/0002-9343(64)90130-5","volume":"37","author":"RE Rieselbach","year":"1964","unstructured":"Rieselbach RE  et al. (1964) Uric acid excretion and renal function in the acute hyperuricemia of leukaemia: pathogenesis and therapy of uric acid nephropathy. Am J Med 37: 872\u2013884","journal-title":"Am J Med"},{"key":"BFncponc0581_CR44","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1001\/archinte.1978.03630280074023","volume":"138","author":"J Kelton","year":"1978","unstructured":"Kelton J  et al. (1978) A rapid method for the diagnosis of acute uric acid nephropathy. Arch Int Med 138: 612\u2013615","journal-title":"Arch Int Med"},{"key":"BFncponc0581_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0300-2977(99)00124-2","volume":"56","author":"JM Van Der Klooster","year":"2000","unstructured":"Van Der Klooster JM  et al. (2000) Asystole during combination chemotherapy for non-Hodgkin's lymphoma: the acute tumor lysis syndrome. Neth J Med 56: 147\u2013152","journal-title":"Neth J Med"},{"key":"BFncponc0581_CR46","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4065\/76.1.67","volume":"76","author":"RC Albright Jr","year":"2001","unstructured":"Albright RC Jr (2001) Acute renal failure: a practical update. Mayo Clin Proc 76: 67\u201374","journal-title":"Mayo Clin Proc"},{"key":"BFncponc0581_CR47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05094.x","volume":"127","author":"MS Cairo","year":"2004","unstructured":"Cairo MS and Bishop M (2004) Tumor lysis syndrome: new therapeutic strategies and classification. Br J Haematol 127: 3\u201311","journal-title":"Br J Haematol"},{"key":"BFncponc0581_CR48","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/oxfordjournals.annonc.a010682","volume":"7","author":"PC Lorigan","year":"1996","unstructured":"Lorigan PC  et al. (1996) Tumour lysis syndrome, case report and review of the literature. Ann Oncol 7: 631\u2013636","journal-title":"Ann Oncol"},{"issue":"Suppl 5","key":"BFncponc0581_CR49","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/S0093-7754(01)90255-6","volume":"28","author":"S Sallan","year":"2001","unstructured":"Sallan S (2001) Management of acute tumor lysis syndrome. Semin Oncol 28 (Suppl 5): S9\u2013S12","journal-title":"Semin Oncol"},{"key":"BFncponc0581_CR50","doi-asserted-by":"publisher","first-page":"722","DOI":"10.4065\/77.7.722","volume":"77","author":"H Sewani","year":"2002","unstructured":"Sewani H and Rabatin JT (2002) Acute tumor lysis syndrome in a patient with mixed small cell and non-small cell tumor. Mayo Clin Proc 77: 722\u2013728","journal-title":"Mayo Clin Proc"},{"key":"BFncponc0581_CR51","first-page":"55","volume":"20","author":"ME Kingston","year":"1974","unstructured":"Kingston ME (1974) Methods of rehydration. J Trop Pediatr Environ Child Health 20: 55\u201356","journal-title":"J Trop Pediatr Environ Child Health"},{"key":"BFncponc0581_CR52","first-page":"325","volume":"4","author":"RE Lynch","year":"1997","unstructured":"Lynch RE  et al. (1997) Renal and metabolic complications of childhood non-Hodgkin's lymphoma. Semin Oncol 4: 325\u2013334","journal-title":"Semin Oncol"},{"key":"BFncponc0581_CR53","first-page":"273","volume":"13","author":"K Arrambide","year":"1993","unstructured":"Arrambide K and Toto RD (1993) Tumor lysis syndrome. Semin Nephrol 13: 273\u2013280","journal-title":"Semin Nephrol"},{"key":"BFncponc0581_CR54","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1172\/JCI108700","volume":"59","author":"JD Conger","year":"1997","unstructured":"Conger JD and Falk SA (1997) Intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy. J Clin Invest 59: 786\u2013793","journal-title":"J Clin Invest"},{"key":"BFncponc0581_CR55","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1001\/archinte.1973.00320120068006","volume":"131","author":"SG Massry","year":"1973","unstructured":"Massry SG  et al. (1973) Excretion of phosphate and calcium: physiology of their renal handling and relation to clinical medicine. Arch Intern Med 131: 828\u2013859","journal-title":"Arch Intern Med"},{"key":"BFncponc0581_CR56","first-page":"47","volume":"22","author":"J Monballyu","year":"1984","unstructured":"Monballyu J  et al. (1984) Transient acute renal failure due to tumor-lysis-induced severe phosphate load in a patient with Burkitt's lymphoma. Clin Nephrol 22: 47\u201350","journal-title":"Clin Nephrol"},{"key":"BFncponc0581_CR57","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1056\/NEJM196603032740902","volume":"274","author":"RC DeConti","year":"1966","unstructured":"DeConti RC and Calabresi P (1966) Use of allopurinol for prevention and control of hyperuricemia in patients with neoplastic disease. N Engl J Med 274: 481\u2013486","journal-title":"N Engl J Med"},{"key":"BFncponc0581_CR58","first-page":"2273","volume":"41","author":"KR Hande","year":"1981","unstructured":"Hande KR  et al. (1981) Postchemotherapy purine excretion in lymphoma patients receiving allopurinol. Cancer Res 41: 2273\u20132279","journal-title":"Cancer Res"},{"key":"BFncponc0581_CR59","first-page":"147","volume":"28","author":"JM Earll","year":"1983","unstructured":"Earll JM and Saavedra M (1983) Oxipurinol therapy in allopurinol-allergic patients. Am Fam Physician 28: 147\u2013148","journal-title":"Am Fam Physician"},{"key":"BFncponc0581_CR60","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0022-3476(86)80387-0","volume":"109","author":"SP Andreoli","year":"1986","unstructured":"Andreoli SP  et al. (1986) Purine excretion during tumor lysis in children with acute lymphocytic leukemia receiving allopurinol: relationship to acute renal failure. J Pediatr 109: 292\u2013298","journal-title":"J Pediatr"},{"key":"BFncponc0581_CR61","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/sj.leu.2400850","volume":"11","author":"CH Pui","year":"1997","unstructured":"Pui CH  et al. (1997) Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies. Leukaemia 11: 1813\u20131816","journal-title":"Leukaemia"},{"key":"BFncponc0581_CR62","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1056\/NEJM196902202800806","volume":"280","author":"ML Greene","year":"1969","unstructured":"Greene ML  et al. (1969) Urinary xanthine stones\u2014a rare complication of allopurinol therapy. N Engl J Med 280: 426\u2013427","journal-title":"N Engl J Med"},{"key":"BFncponc0581_CR63","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1056\/NEJM197008132830708","volume":"283","author":"PR Band","year":"1970","unstructured":"Band PR  et al. (1970) Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol. N Engl J Med 283: 354\u2013357","journal-title":"N Engl J Med"},{"key":"BFncponc0581_CR64","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1182\/blood.V97.10.2998","volume":"97","author":"SC Goldman","year":"2001","unstructured":"Goldman SC  et al. (2001) A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood 97: 2998\u20133003","journal-title":"Blood"},{"key":"BFncponc0581_CR65","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1200\/JCO.2001.19.3.697","volume":"19","author":"CH Pui","year":"2001","unstructured":"Pui CH  et al. (2001) Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma. J Clin Oncol 19: 697\u2013704","journal-title":"J Clin Oncol"},{"key":"BFncponc0581_CR66","first-page":"743","volume":"187","author":"G Leverger","year":"2003","unstructured":"Leverger G and Patte C (2003) Therapeutic progress in acute lymphoblastic leukemias and stage IV Burkitt-type lymphomas in children. Bull Acad Natl Med 187: 743\u2013755","journal-title":"Bull Acad Natl Med"},{"issue":"Suppl 10","key":"BFncponc0581_CR67","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/S0037-1963(01)90038-1","volume":"38","author":"C Patte","year":"2001","unstructured":"Patte C  et al. (2001) European experience in the treatment of hyperuricemia. Semin Hematol 38 (Suppl 10): S9\u2013S12","journal-title":"Semin Hematol"},{"key":"BFncponc0581_CR68","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/annonc\/mdf134","volume":"13","author":"C Patte","year":"2002","unstructured":"Patte C  et al. (2002) Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukaemia, treated in the Societe Francaise d'Oncologie Pediatrique LMB89 protocol. Ann Oncol 13: 789\u2013795","journal-title":"Ann Oncol"},{"key":"BFncponc0581_CR69","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/BF00440958","volume":"11","author":"KG Leach","year":"1985","unstructured":"Leach KG  et al. (1985) Serial measurement of renal plasma flow. Eur J Nucl Med 11: 33\u201335","journal-title":"Eur J Nucl Med"},{"key":"BFncponc0581_CR70","first-page":"202","volume":"7","author":"M Jankovic","year":"1985","unstructured":"Jankovic M  et al. (1985) Urate-oxidase as hypouricemic agent in a case of acute tumor lysis syndrome. Am J Pediatr Hematol Oncol 7: 202\u2013204","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"BFncponc0581_CR71","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S0022-3476(82)80259-X","volume":"100","author":"G Masera","year":"1982","unstructured":"Masera G  et al. (1982) Urate-oxidase prophylaxis of uric acid-induced renal damage in childhood leukemia. J Pediatr 100: 152\u2013155","journal-title":"J Pediatr"},{"key":"BFncponc0581_CR72","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/sj.leu.2402847","volume":"17","author":"PM Navolanic","year":"2003","unstructured":"Navolanic PM  et al. (2003) Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome. Leukemia 17: 499\u2013514","journal-title":"Leukemia"},{"key":"BFncponc0581_CR73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar1861","volume":"8","author":"NJ Ganson","year":"2005","unstructured":"Ganson NJ  et al. (2005) Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene) glycol (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase. Arthritis Res Ther 8: 1\u201310","journal-title":"Arthritis Res Ther"},{"key":"BFncponc0581_CR74","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1038\/sj.leu.2403161","volume":"17","author":"M Hammel","year":"2003","unstructured":"Hammel M  et al. (2003) Successful treatment of hyperuricemia with low dose of recombinant urate oxidase in four patients with haematologic malignancy and tumor lysis syndrome. Leukemia 17: 2542\u20132544","journal-title":"Leukemia"},{"key":"BFncponc0581_CR75","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1136\/ard.40.3.245","volume":"40","author":"GT McInnes","year":"1981","unstructured":"McInnes GT  et al. (1981) Acute adverse reactions attributed to allopurinol in hospitalised patients. Ann Rheum Dis 40: 245\u2013249","journal-title":"Ann Rheum Dis"},{"key":"BFncponc0581_CR76","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/106002809302700317","volume":"27","author":"F Arellano","year":"1993","unstructured":"Arellano F and Sacristan JA (1993) Allopurinol hypersensitivity syndrome: a review. Ann Pharmacother 27: 337\u2013343","journal-title":"Ann Pharmacother"},{"key":"BFncponc0581_CR77","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1007\/s00467-004-1524-y","volume":"19","author":"RJ Macfarlane","year":"2004","unstructured":"Macfarlane RJ  et al. (2004) Rasburicase prevents tumor lysis syndrome despite extreme hyperleukocytosis. Pediatr Nephrol 19: 924\u2013927","journal-title":"Pediatr Nephrol"},{"key":"BFncponc0581_CR78","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/BF02049870","volume":"36","author":"TR Scott","year":"1993","unstructured":"Scott TR  et al. (1993) Colonic necrosis following sodium polystyrene sulphonate (Kayexalate)-sorbitol enema in a renal transplant patient: report of a case and review of the literature. Dis Colon Rectum 36: 607\u2013609","journal-title":"Dis Colon Rectum"},{"issue":"Suppl 5","key":"BFncponc0581_CR79","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S0093-7754(01)90254-4","volume":"28","author":"A Altman","year":"2001","unstructured":"Altman A (2001) Acute tumor lysis syndrome. Semin Oncol 28 (Suppl 5): S3\u2013S8","journal-title":"Semin Oncol"},{"issue":"Suppl","key":"BFncponc0581_CR80","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/S0037-1963(01)90037-X","volume":"10","author":"S Jeha","year":"2001","unstructured":"Jeha S (2001) Tumor Lysis Syndrome. Semin Hematol (Suppl) 10: S4\u2013S8","journal-title":"Semin Hematol"},{"key":"BFncponc0581_CR81","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/S0009-8981(03)00166-9","volume":"333","author":"AA Yarpuzlu","year":"2003","unstructured":"Yarpuzlu AA (2003) A review of clinical and laboratory findings and treatment of tumor lysis syndrome. Clin Chim Acta 333: 1318","journal-title":"Clin Chim Acta"},{"key":"BFncponc0581_CR82","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0002-9343(93)90174-N","volume":"94","author":"KR Hande","year":"1993","unstructured":"Hande KR and Garrow GC (1993) Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma. Am J Med 94: 133\u2013139","journal-title":"Am J Med"},{"key":"BFncponc0581_CR83","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/sj.bmt.1703312","volume":"29","author":"P Frisk","year":"2002","unstructured":"Frisk P  et al. (2002) Renal function after autologous bone marrow transplantation in children: a long term prospective study. Bone Marrow Transplant 29: 129\u2013136","journal-title":"Bone Marrow Transplant"},{"key":"BFncponc0581_CR84","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0272-6386(97)90136-0","volume":"29","author":"TD DuBose Jr","year":"1997","unstructured":"DuBose TD Jr  et al. (1997) Acute renal failure in the 21st century: recommendations for management and outcomes assessment. Am J Kidney Dis 29: 793\u2013799","journal-title":"Am J Kidney Dis"},{"key":"BFncponc0581_CR85","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.amjmed.2003.09.045","volume":"116","author":"MB Davidson","year":"2004","unstructured":"Davidson MB  et al. (2004) Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. Am J Med 116: 546\u2013554","journal-title":"Am J Med"}],"container-title":["Nature Clinical Practice Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncponc0581","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncponc0581.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncponc0581.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T13:13:54Z","timestamp":1744290834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncponc0581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,1]]},"references-count":85,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8,1]]}},"alternative-id":["BFncponc0581"],"URL":"https:\/\/doi.org\/10.1038\/ncponc0581","relation":{},"ISSN":["1743-4254","1743-4262"],"issn-type":[{"value":"1743-4254","type":"print"},{"value":"1743-4262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,1]]},"assertion":[{"value":"15 March 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}